Published Oct. 6, 2026. McKesson and private-equity firm Clayton, Dubilier & Rice have agreed to acquire Option Care Health in a transaction valued at about $5.8 billion, including debt, and take the home-infusion provider private.
Option Care shareholders would receive $32.05 in cash for each share. The buyers said that price represents a roughly 37% premium to the stock’s Oct. 5 closing price.
How ownership would be divided
CD&R would hold a 51% controlling interest after the transaction closes. McKesson plans to invest about $1.4 billion for the remaining 49% and would have a contractual path to acquire CD&R’s stake later.
Option Care Health would remain a separate company under its existing management team. Its common stock would no longer trade publicly on Nasdaq.
Reuters reported the agreement Oct. 6, and the Financial Times also reported the transaction terms.
Why Option Care matters
Option Care is a large independent provider of home and alternate-site infusion therapy. It delivers specialty medications for complex and chronic conditions through patients’ homes and outpatient facilities, serving hundreds of thousands of people each year.
The transaction reflects a wider shift toward providing some complex treatments outside hospitals, where care may be more convenient and less expensive. That potential does not guarantee lower costs for every patient, and insurance coverage, drug pricing and clinical needs still determine individual access.
Closing is not guaranteed
The companies expect the acquisition to close in the first half of 2027. It remains subject to Option Care shareholder approval, regulatory reviews and other customary closing conditions.
Until those requirements are completed, Option Care remains an independent publicly traded company. The $32.05 offer price is the contractual consideration, not a guarantee that shares will trade at that level before closing.
For patients, the announcement does not describe immediate changes to scheduled treatments, pharmacies or clinical services. People receiving infusion care should continue to use their normal provider contacts unless Option Care issues separate instructions.
Follow Business, Finance News and Health News for verified developments.
Featured image: Photo by HH E on Unsplash. Image is illustrative and does not depict Option Care facilities.